176 related articles for article (PubMed ID: 4169706)
21. Clinical and serological studies in Mexico with live attenuated mumps virus vaccine. (Jerry Lynn strain).
Ramos Alvarez M; Bessudo L
Rev Invest Salud Publica; 1972; 32(2):104-8. PubMed ID: 4584449
[No Abstract] [Full Text] [Related]
22. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
23. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
24. Simultaneous administration of live virus vaccines. Measles, mumps, poliomyelitis, and smallpox.
Karchmer AW; Friedman JP; Casey HL; Shope TC; Riker JB; Kappelman MM; Witte JJ
Am J Dis Child; 1971 May; 121(5):382-8. PubMed ID: 4933290
[No Abstract] [Full Text] [Related]
25. Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine.
Minekawa Y; Ueda S; Yamanishi K; Ogino T; Takahashi M
Biken J; 1974 Dec; 17(4):161-7. PubMed ID: 4464833
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and serological studies of live attenuated mumps virus vaccine--inoculation of mumps vaccine singly and in combination with measles vaccine].
Kawanishi K
Kansenshogaku Zasshi; 1971 Feb; 45(2):54-66. PubMed ID: 4995912
[No Abstract] [Full Text] [Related]
27. Observation of the protective effect of live measles vaccines in the first year after vaccination.
Sejda J; Helcl J; Strauss J
J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
[No Abstract] [Full Text] [Related]
28. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2001 Oct; 184(7):817-26. PubMed ID: 11528592
[TBL] [Abstract][Full Text] [Related]
29. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
Sekiguchi H; Numazaki Y; Ikeda M; Yano N
Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
[No Abstract] [Full Text] [Related]
30. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
31. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
32. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
33. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
[TBL] [Abstract][Full Text] [Related]
34. Experience with live-virus mumps vaccine.
J Iowa Med Soc; 1968 Sep; 58(9):955-7. PubMed ID: 5683277
[No Abstract] [Full Text] [Related]
35. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
[No Abstract] [Full Text] [Related]
36. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
[TBL] [Abstract][Full Text] [Related]
37. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
Santo K
Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
[No Abstract] [Full Text] [Related]
38. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination.
Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N
Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905
[No Abstract] [Full Text] [Related]
39. Vaccination against virus disease.
Krugman S
Maandschr Kindergeneeskd; 1968 Nov; 36(7):198-206. PubMed ID: 5715991
[No Abstract] [Full Text] [Related]
40. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
